Indication
Reduction of allogeneic blood transfusion in surgery
Reduction of allogeneic blood transfusion in surgery is not an intrinsic disease, but rather a clinical and therapeutic objective in patient blood management. Read more about Reduction of allogeneic blood transfusion in surgery
5 drugs 5 manufacturers
Drugs that treat it
Common Reduction of allogeneic blood transfusion in surgery therapies.
EPOGEN (epoetin alfa)
PROCRIT (epoetin alfa)
RETACRIT (epoetin alfa-epbx)
RETACRIT (epoetin alfa-epbx)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonReduction of allogeneic blood transfusion in surgery is not an intrinsic disease, but rather a clinical and therapeutic objective in patient blood management.
It addresses the hematologic complication of acute perioperative blood loss and surgical anemia in patients undergoing major elective or emergency procedures.
Severe blood loss compromises oxygen-carrying capacity and hemodynamic stability, historically necessitating donor red blood cell administration.
Limiting exposure to allogeneic blood aims to mitigate transfusion-associated risks, including transfusion-related acute lung injury, hemolytic or febrile reactions, immunomodulation, surgical site infections, and transmission of bloodborne pathogens.
- perfusion.com
Reduction of allogeneic blood transfusion in surgery is not an intrinsic disease, but rather a clinical and therapeutic objective in patient blood management
- redcross.org
Reduction of allogeneic blood transfusion in surgery is not an intrinsic disease, but rather a clinical and therapeutic objective in patient blood management
- radiustx.com
It addresses the hematologic complication of acute perioperative blood loss and surgical anemia in patients undergoing major elective or emergency procedures Severe blood loss compromises oxygen-carrying capacity and hemodynamic stability, historically necessitating donor red blood cell administration Limiting exposure to allogeneic blood aims to mitigate transfusion-associated risks, including transfusion-related acute lung injury, hemolytic or febrile reactions, immunomodulation, surgical site...
- viamedica.pl
It addresses the hematologic complication of acute perioperative blood loss and surgical anemia in patients undergoing major elective or emergency procedures
- govinfo.gov
Severe blood loss compromises oxygen-carrying capacity and hemodynamic stability, historically necessitating donor red blood cell administration Limiting exposure to allogeneic blood aims to mitigate transfusion-associated risks, including transfusion-related acute lung injury, hemolytic or febrile reactions, immunomodulation, surgical site infections, and transmission of bloodborne pathogens
- nih.gov
Limiting exposure to allogeneic blood aims to mitigate transfusion-associated risks, including transfusion-related acute lung injury, hemolytic or febrile reactions, immunomodulation, surgical site infections, and transmission of bloodborne pathogens
Personalize your experience
Follow Reduction of allogeneic blood transfusion in surgery and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.